Muscles and meth: Drug analog identified in 'craze' workout supplement

An international team of scientists have identified potentially dangerous amounts of methamphetamine analog in the workout supplement Craze, a product widely sold across the U.S. and online. The study, published in Drug Testing and Analysis, was prompted by a spate of failed athletic drug tests. The results reveal the presence of methamphetamine analog N,α- DEPEA, which has not been safely tested for human consumption, in three samples.

"In recent years banned and untested drugs have been found in hundreds of dietary supplements. We began our study of Craze after several athletes failed urine because of a new methamphetamine analog," said lead author Dr. Pieter Cohen, of Harvard Medical School, U.S.A.

A workout supplement marketed as a 'performance fuel', Craze is manufactured by Driven Sports, Inc., and is sold in stores across the United States and internationally via body supplement websites.

The supplement is labeled as containing the compound N,N-diethyl-phenylethylamine (N,N-DEPEA), claiming it is derived from endangered dendrobium orchids. However, while there is no proof that this compound is found within orchids, it is also structurally similar to the methamphetamine analog N,?-diethylphenylethylamine (N,alpha-DEPEA), a banned substance.

The team analyzed three samples of Craze for traces of N,alpha-DEPEA. The first sample was brought from a mainstream retailer in the U.S., while the second and third samples were ordered from online retailers in the U.S. and Holland.

The team used ultra-high performance liquid chromatography to detect the presence of N,?-DEPEA. The first two samples were analyzed by NSF International, while the third was tested at the Netherland's National Institute for Public Health. The findings were independently corroborated by the Korean Forensic Service, which confirmed the presence of N,?-DEPEA in two further samples of Craze in a parallel investigation.

"We identified a potentially dangerous designer drug in three separate samples of this widely available ," said Cohen. "The tests revealed quantities of N,?-DEPEA of over 20mg per serving, which strongly suggests that this is not an accidental contamination from the manufacturing process."

As a structural analog of methamphetamine, N,?-DEPEA , may have stimulant and addictive qualities; however, it has never been studied in humans and its adverse effects remain unknown.

The product labeling claims that Craze contains several organic compounds, known as phenylethylamines. However, phenylethylamines are a very broad category of chemicals which range from harmless compounds found in chocolate to synthetically produced illegal drugs.

"The phenylethylamine we identified in Craze, N,alpha-DEPEA, is not listed on the labeling and it has not been previously identified as a derivative of dendrobium orchids," said Cohen.

"If these findings are confirmed by regulatory authorities, the FDA (The U.S. Food and Drug Administration) must take action to warn consumers and to remove supplements containing N,alpha-DEPEA from sale," concluded Cohen. "Our fear is that the federal shutdown may delay this, resulting in potentially dangerous supplements remaining widely available."

More information: Cohen. P, Travis. J, Venhuis. B, A methamphetamine analog (N,alpha-diethyl-phenylethylamine) identified in a mainstream dietary supplement, Drug Testing and Analysis. DOI: 10.1002/dta.1578

add to favorites email to friend print save as pdf

Related Stories

FDA warns of steroids in vitamin B supplement

Jul 27, 2013

(AP)—The Food and Drug Administration is warning consumers to avoid a vitamin B dietary supplement from Healthy Life Chemistry by Purity First because it contains two potentially dangerous anabolic steroids.

FDA warns consumers of dangers of the stimulant DMAA

Apr 15, 2013

(HealthDay)—The U.S. Food and Drug Administration is attempting to halt distribution of dietary supplements that contain the stimulant dimethylamylamine (DMAA), following reports of illness and death associated ...

Researchers tackle designer drug craze

Jul 16, 2012

(Medical Xpress) -- President Obama signed a bill into law this week designating certain chemicals found in designer drugs as FDA-controlled substances.

Recommended for you

Drug research and development more efficient than expected

Feb 27, 2015

Drug R&D costs have increased substantially in recent decades, while the number of new drugs has remained fairly constant, leading to concerns about the sustainability of drug R&D and question about the factors that could ...

Use new meningitis vaccines only for outbreaks

Feb 26, 2015

(AP)—A U.S. panel on Thursday recommended that two new meningitis vaccines only be used for rare outbreaks, resisting tearful pleas to give it routinely to teens and college students.

New antibiotic avycaz approved

Feb 26, 2015

(HealthDay)—The combination antibiotic Avycaz (ceftazidime-avibactam) has been approved by the U.S. Food and Drug Administration to treat adults with complicated infections of the intra-abdominal area or urinary tract, ...

Tagging drugs to fight counterfeit medicines

Feb 25, 2015

The U.S. and other countries are enacting rules to clamp down on the sales of fake pharmaceuticals, which pose a public health threat. But figuring out a system to track and authenticate legitimate drugs still faces significant ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.